BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25868656)

  • 21. Effect of the antimicrobial peptide, D-hecate, on trichomonads.
    Mutwiri GK; Henk WG; Enright FM; Corbeil LB
    J Parasitol; 2000 Dec; 86(6):1355-9. PubMed ID: 11191917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of lytic peptide-bound magnetite nanoparticles in destroying breast cancer cells.
    Kumar CS; Leuschner C; Doomes EE; Henry L; Juban M; Hormes J
    J Nanosci Nanotechnol; 2004 Mar; 4(3):245-9. PubMed ID: 15233083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-tumor activities of the host-defense peptide hymenochirin-1B.
    Attoub S; Arafat H; Mechkarska M; Conlon JM
    Regul Pept; 2013 Nov; 187():51-6. PubMed ID: 24185042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The morphological effects of two antimicrobial peptides, hecate-1 and melittin, on Escherichia coli.
    Henk WG; Todd WJ; Enright FM; Mitchell PS
    Scanning Microsc; 1995 Jun; 9(2):501-7. PubMed ID: 8714745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model peptides mimic the structure and function of the N-terminus of the pore-forming toxin sticholysin II.
    Casallanovo F; de Oliveira FJ; de Souza FC; Ros U; Martínez Y; Pentón D; Tejuca M; Martínez D; Pazos F; Pertinhez TA; Spisni A; Cilli EM; Lanio ME; Alvarez C; Schreier S
    Biopolymers; 2006; 84(2):169-80. PubMed ID: 16170802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melittin peptides exhibit different activity on different cells and model membranes.
    Jamasbi E; Batinovic S; Sharples RA; Sani MA; Robins-Browne RM; Wade JD; Separovic F; Hossain MA
    Amino Acids; 2014 Dec; 46(12):2759-66. PubMed ID: 25200682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted ablation of prostate carcinoma cells through LH receptor using Hecate-CGbeta conjugate: functional characteristic and molecular mechanism of cell death pathway.
    Bodek G; Kowalczyk A; Waclawik A; Huhtaniemi I; Ziecik AJ
    Exp Biol Med (Maywood); 2005 Jun; 230(6):421-8. PubMed ID: 15956772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alkyl esters of gallic acid as anticancer agents: a review.
    Locatelli C; Filippin-Monteiro FB; Creczynski-Pasa TB
    Eur J Med Chem; 2013 Feb; 60():233-9. PubMed ID: 23291333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticancer activity of phenolic acids of natural or synthetic origin: a structure-activity study.
    Gomes CA; da Cruz TG; Andrade JL; Milhazes N; Borges F; Marques MP
    J Med Chem; 2003 Dec; 46(25):5395-401. PubMed ID: 14640548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gallic acid enhancement of gold nanoparticle anticancer activity in cervical cancer cells.
    Daduang J; Palasap A; Daduang S; Boonsiri P; Suwannalert P; Limpaiboon T
    Asian Pac J Cancer Prev; 2015; 16(1):169-74. PubMed ID: 25640346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis).
    Wang C; Li HB; Li S; Tian LL; Shang DJ
    Biochimie; 2012 Feb; 94(2):434-41. PubMed ID: 21871946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conjugates of lytic peptides and LHRH or betaCG target and cause necrosis of prostate cancers and metastases.
    Hansel W; Leuschner C; Enright F
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):26-33. PubMed ID: 17382461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Furan-Conjugated Tripeptides as Potent Antitumor Drugs.
    Ali H; Jabeen A; Maharjan R; Nadeem-Ul-Haque M; Aamra H; Nazir S; Khan S; Olleik H; Maresca M; Shaheen F
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo antimicrobial peptides with low mammalian cell toxicity.
    Javadpour MM; Juban MM; Lo WC; Bishop SM; Alberty JB; Cowell SM; Becker CL; McLaughlin ML
    J Med Chem; 1996 Aug; 39(16):3107-13. PubMed ID: 8759631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
    Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
    Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary gallic acid and anthocyanin cytotoxicity on human fibrosarcoma HT1080 cells. A study on the mode of action.
    Filipiak K; Hidalgo M; Silvan JM; Fabre B; Carbajo RJ; Pineda-Lucena A; Ramos A; de Pascual-Teresa B; de Pascual-Teresa S
    Food Funct; 2014 Feb; 5(2):381-9. PubMed ID: 24413695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of N-terminus modifications on the biological activity, membrane interaction, and secondary structure of the antimicrobial peptide hylin-a1.
    Crusca E; Rezende AA; Marchetto R; Mendes-Giannini MJ; Fontes W; Castro MS; Cilli EM
    Biopolymers; 2011; 96(1):41-8. PubMed ID: 20560142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study.
    Oren Z; Shai Y
    Biochemistry; 1997 Feb; 36(7):1826-35. PubMed ID: 9048567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity analysis of the antitumor and hemolytic properties of the amphiphilic alpha-helical peptide, C18G.
    Peck-Miller KA; Blake J; Cosand WL; Darveau RP; Fell HP
    Int J Pept Protein Res; 1994 Aug; 44(2):143-51. PubMed ID: 7982758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumour activity and specificity as a function of substitutions in the lipophilic sector of helical lactoferrin-derived peptide.
    Yang N; Lejon T; Rekdal O
    J Pept Sci; 2003 May; 9(5):300-11. PubMed ID: 12803496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.